Exercise Therapy for PAD Using Mobile Health

Study acronym: Smart MOVE
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 30 days later Sep 30, 2026 → Oct 30, 2026
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from VA Office of Research and Development

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Primary endpoint(s) modified Show 5 more changesShow less
    • Enrollment closed, study ongoing
    • Primary and study completion pushed from Sep 30, 2026 to Oct 30, 2026
    • Final enrollment: 63 participants (planned 75)
    • Eligibility criteria expanded, about 43 words
    • Site details revised
  3. Primary completion date: Mar 31, 2026 to Sep 30, 2026
    • Site contact updated
    v10
  4. 2 versions Re-verified since Sep 20, 2024, no change to tracked fieldsv8-v9
  5. Collaborator revisedv7
Show 5 earlier versionsHide 5 earlier versions
  1. Site details revised
    • Collaborators expanded, about 2 words
    v6
  2. Site contact updatedv5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  4. Start date: Nov 1, 2021 to Dec 1, 2021v3
  5. Interventions: General Walking Advice (Usual Care) (Behavioral), N-of-1 Trials (Behavioral), Smart MOVE! (Behavioral) to General walking advice (Behavioral), Performance evaluation (Behavioral), Smart MOVE! (Behavioral)
    • Site contact updated
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Peripheral artery disease (PAD) is a highly prevalent condition affecting up to 10% of Veterans that leads to loss of walking ability and increased risk of amputation. Veterans have limited access to supervised exercise therapy, a facility-based program proven to improve walking ability in PAD, which is poorly attended due to the inconvenience and cost of attending a 12-week program with multiple weekly sessions. This CDA-2 application will investigate the feasibility of home-based exercise therapy (HBET) delivered using mobile health (mHealth) technologies in Veterans with symptomatic PAD. We will partner with the MOVE! program to deliver HBET through group behavioral coaching and a novel wearable activity monitor in a newly proposed program called Smart MOVE!. There is a clear need to provide effective and convenient alternatives to supervised exercise for Veterans with PAD. This study will provide evidence to proceed with Smart MOVE!, a much-needed patient-centered rehabilitation program for Veterans with PAD.
Trial Details
NCT Number NCT04889105
Lead Sponsor VA Office of Research and Development
Collaborators: LifeQ
Conditions
(from sponsor)		 Peripheral Artery Disease
Related terms Peripheral Arterial Disease
Enrollment 63 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov